Skip to content
ReframedNewsLeft · Right · Centered
Quick ReadArchiveAboutSign in
Briefing stories›Science & Climate

Trial data show daraxonrasib extended survival in previously treated metastatic pancreatic cancer

Story date · Sunday, May 31, 2026Science & ClimateWell-covered

The facts

  • A clinical trial found that daraxonrasib improved survival compared with chemotherapy in patients with previously treated metastatic pancreatic cancer.
  • Multiple reports said the trial included 500 patients.
  • Reported average survival was 13.2 months for patients receiving daraxonrasib versus 6.6 months for patients receiving chemotherapy.
  • Daraxonrasib was reported as a once-daily oral pill in the trial.
  • Several reports said daraxonrasib caused fewer severe side effects than chemotherapy.
  • The trial results were presented at the American Society of Clinical Oncology meeting in Chicago and were published in The New England Journal of Medicine.
  • Reports said daraxonrasib targets KRAS-related tumor growth, and KRAS mutations are found in more than 90% of pancreatic cancers.
  • The drug is still experimental, and at least one report said it has been fast-tracked by the U.S. Food and Drug Administration for approval.

Context

Who were the patients in this trial?

The study involved patients with metastatic pancreatic cancer whose disease had already been treated and was no longer responding to prior chemotherapy; reports also describe the trial as enrolling 500 patients across North America, Europe and Asia BBC,India Today,Yahoo! Finance.

How does daraxonrasib work?

Reports say daraxonrasib blocks KRAS-driven tumor growth. That matters because KRAS mutations are found in more than 90% of pancreatic tumors, making it a widely relevant target in this cancer Yahoo! Finance,Independent,CBS News.

What is still unresolved?

Daraxonrasib is still an experimental drug, so the next steps are regulatory review and decisions about broader clinical use. One report says the FDA has fast-tracked it for approval, but the sources provided do not say that approval has yet been granted NBC News,DIE WELT.

Common ground, and where they split

Common ground
An experimental once-daily pill beat chemotherapy in previously treated metastatic pancreatic cancer on both survival and severe side effects, a result serious enough to suggest KRAS-targeted treatment may offer a more effective, more tolerable path than standard care.
Where Left and Right split
Less a disagreement than a question of emphasis: a more tolerable, more precisely targeted direction for care versus the strength and credibility of a 500-patient result presented at ASCO and published in The New England Journal of Medicine.

How left and right read it

Left says

This result stands out because an experimental treatment not only improved survival over chemotherapy in previously treated metastatic pancreatic cancer, but did so with reported average survival of 13.2 months versus 6.6 months and fewer severe side effects. A once-daily oral pill that targets KRAS-related tumor growth in a disease where KRAS mutations are found in more than 90% of cases points to a more tolerable, more precisely targeted direction for care.

Right says

This result stands out because an experimental once-daily oral pill in a 500-patient trial reportedly doubled average survival over chemotherapy, from 6.6 months to 13.2 months, while also causing fewer severe side effects. With findings presented at ASCO and published in The New England Journal of Medicine, it’s a serious signal that targeted treatment of KRAS-related tumor growth may be delivering real gains.

See this differently than someone you know would?

The receipts — 95 sources

Wire services (4)

APThe Telegraph'Breakthrough' pill doubles life expectancy for pancreatic c...
APYahoo! FinanceExperimental pill promises new hope for deadly pancreatic ca...
ReutersReutersRevolution's pancreatic cancer drug doubles survival, boosts...
APBreitbartExperimental pill promises new hope for deadly pancreatic ca...

Other coverage (91)

N-tvWirkstoff erzielt "Durchbruch": Studie: Überlebenszeit bei g...
wallstreet:onlineImmuneering Presents Compelling 17.3-Month Median Overall Su...
India TodayNew pill becomes game changer for pancreatic cancer, doubles...
ProPakistaniNew Pill Doubles Survival Time Among Advanced Pancreatic Can...
Sözcü GazetesiBu hap pankreas kanseri hastalarına umut oldu: Ömürleri iki ...
MorningstarDoctors stood up and cheered mid-presentation for this histo...
Herald Sun'Absolutely phenomenal': Single pill offers hope against dea...
LaSextaIdentifican un tratamiento que duplica la supervivencia en c...
MorningstarWhy doctors stood up and cheered mid-presentation for a hist...
Franceinfo"Une vague de biotechnologies porteuse d'espoir" : les nouve...
Express.co.ukBreakthrough against 'most-feared' cancer hailed by doctors ...
LADbibleNew daily pill can double survival time for world's deadlies...
DikenYeni deneysel ilaç: Pankreas kanserinde yaşam süresini uzatı...
TürkiyePankreas kanseri hastalarına müjde! Yeni geliştirilen ilaç, ...
Anadolu AjansıAraştırmaya göre, yeni deneysel ilaç bazı pankreas kanseri t...
HaberlerAraştırmaya göre, yeni deneysel ilaç bazı pankreas kanseri t...
FanpageTumore al pancreas, pillola daraxonrasib raddoppia la soprav...
FranceinfoCancer du pancréas : "On a ouvert une porte" avec ce nouveau...
TodaySvolta sul tumore al pancreas: la nuova pillola raddoppia la...
ITV HubNew pill helps double survival time for people with advanced...
KCRAExperimental pill promises new hope for deadly pancreatic ca...
BBCDaily pill daraxonrasib doubles survival time for pancreatic...
The Times of IndiaExperimental pill promises new hope for deadly pancreatic ca...
www.theepochtimes.comUCLA-Led Study Finds New Pancreatic Cancer Drug 'Significant...
MyJoyOnline.comDaily pill doubles survival time for pancreatic cancer patie...
Lenta.ruСтало известно об успешных испытаниях новой вакцины против р...
Беларускае тэлеграфнае агенцтваЭкспериментальная вакцина от рака в США вызвала улучшение у ...
ФедералПресс"Огромный шаг вперед": ученые заявили о прорыве в лечении ра...
Пятый канал - Главные новости России и мира сегодняThe Guardian сообщила об успешных испытаниях новой вакцины о...
La NacionCumbre anual de oncólogos: tres desafíos que persisten para ...
Izvestia.ruThe Guardian сообщила об успешных испытаниях новой вакцины п...
РИА НовостиЭкспериментальная вакцина от рака в США вызвала улучшение у ...
Corriere della SeraTumore del pancreas, un nuovo farmaco rivoluziona le cure
Radio SarajevoNova terapija protiv raka dala neviđene rezultate: "Ovaj tre...
Аргументы и фактыНовая вакцина против рака уничтожила опухоли у 15 тяжелоболь...
kp.ruGuardian: Экспериментальная вакцина от рака уничтожила опухо...
Life.ruThe Guardian: Новая вакцина уничтожила опухоли у пациентов с...
Московский КомсомолецThe Guardian: экспериментальная вакцина от рака уничтожила о...
vesti.ruВрачи рассказали об убивающей раковые опухоли онковакцине - ...
NewserPancreatic Cancer Trial Shows Pill Doubling Survival Rates
inews.co.ukWhy this new pill for a deadly cancer has doctors excited
Primera HoraPíldora experimental promete nueva esperanza contra el cánce...
ANSA.itEsperto, 'per pazienti con tumore al pancreas si apre un nuo...
Вечерняя МоскваThe Guardian: Экспериментальная вакцина уничтожила опухоли у...
20 minutosUn ensayo identifica un tratamiento que duplica la supervive...
La Presse.caLutte contre le cancer du pancréas | Un médicament offre un ...
NBC ChicagoAfter new drug's 'unprecedented' results for pancreatic canc...
VestiПрорыв в лечении рака? Новый препарат излечил более 40 проце...
TelemundoUna pastilla experimental ofrece esperanza ante el cáncer de...
Cadena SERUna pastilla al día podría aumentar el doble la esperanza de...
DAGOSPIAl farmaco sperimentale daraxonrasib, ha quasi raddoppiato la...
CBS NewsNew drug nearly doubles survival rates in some pancreatic ca...
RedstateNew Cancer Drug Opens Floodgates of Hope Beyond Pancreatic C...
Daily RecordNew pill for advanced pancreatic cancer patients helps doubl...
L'Humanité" Cette molécule est une révolution qui va changer nos prati...
El Nuevo DíaEs un gran paso": píldora experimental promete nueva esperan...
The Straits TimesExperimental pancreatic cancer pill doubles survival
slobodna-bosna.baNOVA TERAPIJA PROTIV RAKA DALA NEVIĐENE REZULTATE: 'Ovaj tre...
abc15 ArizonaExperimental pill promises new hope for deadly pancreatic ca...
Investing.comRevolution Medicines reports phase 3 pancreatic cancer trial...
Il MessaggeroTumore pancreas, nuova terapia "raddoppia sopravvivenza con ...
The Times of IsraelDaily pill nearly doubled survival time for people with adva...
ANSA.it>>>ANSA/Dopo anni nuova terapia per tumore pancreas, raddopp...
DIE WELTNeues Medikament: Daraxonrasib verdoppelt die Überlebenszeit...
MirrorCancer breakthrough as new 'game-changing' pill could double...
Süddeutsche Zeitung"Revolutionärer Durchbruch" bei Behandlung von Bauchspeichel...
wallstreet:onlineRevolution Medicines Announces ASCO Plenary Presentation Hig...
EXPRESSCancer 'Holy Grail' discovered in breakthrough that doubled ...
Barchart.comRevolution Medicines Announces ASCO Plenary Presentation Hig...
EL PAÍSVuelta de tuerca en el tumor más letal: una terapia dirigida...
The GuardianDaily pill can double survival time for world's deadliest ca...
The IndependentDaily pill almost doubles survival time for pancreatic cance...
Washington Post'Landmark' pancreatic cancer drug keeps patients alive for t...
NBC NewsAfter new drug's 'unprecedented' results for pancreatic canc...
Bloomberg BusinessRevMed Drug Delays Painful Cancer Symptoms While Extending L...
STATPractice-changing results reported for Revolution Medicines ...
TribLIVEExperimental pill promises new hope for deadly pancreatic ca...
Novi listNada za one kojima kemoterapija ne pomaže: Injekcija protiv ...
RTVIНовая вакцина убила раковые опухоли 15 пациентов, которым не...
Dnevnik.hrNova terapija protiv raka dala neviđene rezultate: "Ovaj tre...
vijesti.meIspitivanje pokazalo: Injekcija protiv raka može da iskorije...
Московский КомсомолецИсследование показало способность инъекции против рака полно...
Vecernji.hrInjekcija protiv raka s trostrukim djelovanjem donosi dosad ...
FOX 13 Tampa BayExperimental pill helps people with advanced pancreatic canc...
ZN.UAНовейшая инъекция может уничтожать раковые опухоли -- исслед...
ZN.UAНовітня ін'єкція може знищувати ракові пухлини -- дослідженн...
Klix.baNovo ispitivanje pokazalo ohrabrujući rezultat: Vakcina uklo...
STATRevolution Medicines starts shipping experimental pancreatic...
Franceinfo"C'est une révolution" : pourquoi le daraxonrasib, un nouvea...
PBS.orgPancreatic cancer is deadly and difficult to treat. A new pi...
SciTechDailyScientists Stop Pancreatic Cancer Before It Starts in Landma...

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

← Earlier in this briefing
Google seeks U.S. approval to release up to 32 million mosquitoes in California ...
Google, through Alphabet life sciences unit Verily's Debug project, has asked the U.S. Environmental Protection Agency...
Science & Climate
Next in this briefing →
Philippines and Vietnam elevate relations and renew defense cooperation during T...
The Philippines and Vietnam said they are elevating their relationship to an enhanced strategic partnership during...
International Affairs

Continue Reading

More in Science & Climate

Developing El Niño is expected to shift 2026 hurricane activity toward the Pacific and away from the Atlantic

As the 2026 Eastern Pacific hurricane season begins, multiple forecasts say a developing El Niño is likely to increase...

Science & Climate
Related this week

Report: Mossad shared warning with CIA about possible Iranian drone attacks on Trump

Israel Hayom reported that Mossad shared intelligence with the CIA alleging that Iran could target President Donald...

International Affairs
From this briefing

US and Iran exchange new strikes near the Gulf as ceasefire talks continue

The United States said it carried out strikes on Iranian radar and drone command sites in Goruk and on Qeshm Island...

U.S. Politics
Back to all stories

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

ReframedNews

A daily news briefing on the day’s top stories, built to show both sides.

Written by AI from news reporting. We review published briefings. Who writes this →

Navigate

Quick ReadArchiveSettings

Company

AboutHow it worksSkylark CreationsSign InTerms of ServicePrivacy Policy

© 2026 Reframed.News

Made by Skylark Creations